Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 472 | 0 | −472 (−100.0%) |
| Value | $20.7K | $0 | −$20.7K (−100.0%) |
New holders (0)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
None.
Sold out (2)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| IFP Advisors, Inc | 346 | $15.5K |
| Ronald Blue Trust, Inc. | 126 | $5.15K |